Effects of Oral Liposomal Glutathione in Altering the Immune Responses Against Mycobacterium tuberculosis and the Mycobacterium bovis BCG Strain in Individuals With Type 2 Diabetes

The World Health Organization (WHO) has identified type 2 diabetes (T2DM) as a neglected, important, and re-emerging risk factor for tuberculosis (TB), especially in low and middle-income countries where TB is endemic. In this clinical trial study, oral liposomal glutathione supplementation (L-GSH)...

Full description

Bibliographic Details
Main Authors: Kimberly To, Ruoqiong Cao, Aram Yegiazaryan, James Owens, Timothy Nguyen, Kayvan Sasaninia, Charles Vaughn, Mohkam Singh, Edward Truong, Albert Medina, Edith Avitia, Jose Villegas, Christal Pham, Airani Sathananthan, Vishwanath Venketaraman
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcimb.2021.657775/full

Similar Items